id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-2002-2029,FDA,FDA-2015-N-2002,Kalb et al_IU Final Rule_Response_3-26-18,Other,Agency Response,2018-04-09T04:00:00Z,2018,4,2018-04-09T04:00:00Z,,2018-04-09T21:10:24Z,,0,0,09000064830e95e3
FDA-2015-N-2002-2028,FDA,FDA-2015-N-2002,"Clarification of When Products Made or Derived From Tobacco Are
Regulated as Drugs, Devices, or Combination Products; Amendments
to Regulations Regarding ‘‘Intended Uses’’; Partial Delay of Effective Date",Rule,Final Rule,2018-03-16T04:00:00Z,2018,3,2018-03-16T04:00:00Z,,2018-03-16T14:18:37Z,2018-05347,0,0,090000648301bfb5
FDA-2015-N-2002-2008,FDA,FDA-2015-N-2002,"Clarification of When Products Made or Derived From Tobacco Are
Regulated as Drugs, Devices, or Combination Products; Amendments
to Regulations Regarding ‘‘Intended Uses’’; Proposed Partial Delay of
Effective Date",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2018-01-16T05:00:00Z,2018,1,2018-01-16T05:00:00Z,2018-02-06T04:59:59Z,2018-02-06T14:02:16Z,2018-00555,0,0,0900006482e0b3c7